If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStatPro Regulatory News (SOG)

  • There is currently no data for SOG

Director's Interests

31 Mar 2015 12:45

RNS Number : 0084J
StatPro Group PLC
31 March 2015
 



31 March 2015

 

StatPro Group PLC

 

Director's Interests

 

StatPro Group plc, (AIM:SOG, "StatPro", "the Company"), the AIM listed provider of cloud-based portfolio analysis and asset pricing services for the global asset management industry, announces that, following the approval by shareholders of the new Performance Share Plan ("PSP") at its General Meeting held on 26 February 2015, the Remuneration Committee of the Board has granted nil-cost options over ordinary shares in the Company ("Awards") on 30 March 2015 under the PSP, as set out below:

 

Awards granted pursuant to the PSP

Award Holder

Number of options granted over ordinary shares

subject to Award

Vesting Date

Andrew Fabian, Finance Director

40,000

3rd anniversary of Award Date

40,000

4th anniversary of Award Date

Other Executives

315,000

3rd anniversary of Award Date

315,000

4th anniversary of Award Date

 

Andrew Fabian's holding in the Company remains unchanged at 264,647 ordinary shares, representing approximately 0.39 per cent. of the Company's issued share capital. Following the grant of Awards, he now holds options over 400,000 ordinary shares, including the 80,000 options granted under the Award.

 

Enquiries:

 

StatPro Group plc

Justin Wheatley, Chief Executive

020 8410 9876

Andrew Fabian, Finance Director

Cenkos Securities

Stephen Keys / Dr Christopher Golden

020 7397 8900

Instinctif Partners

Adrian Duffield/ Kay Larsen

020 7457 2020

 

About StatPro

StatPro is a global provider of award winning portfolio analytics solutions for the investment community. The Group's cloud-based platform provides vital analysis of portfolio performance, attribution, risk and compliance. Thousands of investment professionals use StatPro's premium services directly or through a fund administrator or partner to perform advanced portfolio analysis, data management, reporting and online distribution every day. This multi asset-class, analytics platform helps StatPro's clients increase assets under management, improve client service, meet tough regulations and reduce costs.

 

With over 20 years' experience combining technology and industry expertise, StatPro believes portfolio analytics should add value, insight and competitive advantage while being flexible, scalable and cost effective. The Group's integrated and global data coverage includes over 3.2 million securities such as equities, bonds, mutual funds, FX rates, futures, options, OTCs, sector classifications and much else besides. StatPro also covers most families of benchmarks including MSCI, FTSE, Russell, NASDAQ and the licence free Freedom Index.

 

StatPro has grown its recurring revenue from less than £1 million in 1999 to around £29 million at 31 December 2014. StatPro floated on the main market of the London Stock Exchange in May 2000 and transferred its listing to AIM in June 2003. The Group has operations in Europe, North America, South Africa, Asia and Australia, and approximately 500 clients in 37 countries around the world. Approximately 80% of recurring revenues are generated outside the UK.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZMGFFMMRGKZM
Date   Source Headline
28th Sep 20167:00 amRNSLaunch of StatPro Revolution Performance
21st Sep 20165:37 pmRNSHolding(s) in Company
20th Sep 20165:04 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNS£1m contract win with North American asset manager
5th Sep 20167:00 amRNS£1.5m StatPro Seven contract win
3rd Aug 20167:00 amRNSInterim results
19th Jul 20167:00 amRNSHalf year trading update
14th Jul 20169:00 amRNSNotice of Results
14th Jun 20167:00 amRNSFurther major international contract win
6th Jun 20167:00 amRNS£2.3m contract with large Australian institution
19th May 20165:34 pmRNSResult of AGM
19th May 20167:00 amRNSDirectorate Change
19th May 20167:00 amRNSAGM statement and trading update
14th Apr 20164:34 pmRNSDirectors' Interests
12th Apr 20165:00 pmRNSPosting of Annual Report and Notice of AGM
5th Apr 20169:06 amRNSDirectorate Change
16th Mar 201611:02 amRNSHolding(s) in Company
15th Mar 201610:03 amRNSHolding(s) in Company
14th Mar 20167:00 amRNSTransaction in Own Shares
10th Mar 20167:00 amRNSDirectors' dealings
9th Mar 20167:00 amRNSFinal Results
2nd Mar 20169:49 amRNSHolding(s) in Company
12th Feb 20167:00 amRNSAcquires majority shareholding in InfoVest
11th Feb 201610:00 amRNSNotice of Results
29th Jan 20167:00 amRNSYear End trading update
22nd Jan 20167:00 amRNSAcquisition of Investor Analytics
6th Jan 20161:21 pmRNSHolding(s) in Company
14th Dec 20157:00 amRNSStatPro Revolution launches version 65
19th Oct 20157:00 amRNSQ3 trading update
25th Sep 201512:35 pmRNSHolding(s) in Company
25th Sep 201512:30 pmRNSHolding(s) in Company
5th Aug 20157:00 amRNSInterim results
22nd Jul 201510:00 amRNSNotice of Results
15th Jul 20157:00 amRNSHalf year trading update
11th Jun 20159:39 amRNSDirectors' dealings
5th Jun 201512:48 pmRNSDirectors' dealings
29th May 20157:00 amRNSChange of Adviser
20th May 20151:54 pmRNSResult of AGM
20th May 20157:00 amRNSAGM statement and trading update
16th Apr 201510:03 amRNSPosting of Annual Report and notice of AGM
31st Mar 201512:45 pmRNSDirector's Interests
11th Mar 20159:05 amRNSIssue of Shares
10th Mar 20157:03 amRNSFinal Results
26th Feb 20152:04 pmRNSReplacement - Result of General Meeting
26th Feb 20151:15 pmRNSPosting of Circular and Notice of General Meeting
24th Feb 201510:00 amRNSNotice of Results
9th Feb 20155:00 pmRNSPosting of Circular and Notice of General Meeting
22nd Jan 20157:00 amRNSTrading Update and Notice of Results
8th Jan 201512:37 pmRNSHolding(s) in Company
6th Jan 20157:00 amRNSContract win with large European Asset Manager

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.